MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate
Abstract
Share and Cite
Zhang, Q.; Lin, J.; Zhang, Z.; Han, L.; Huang, Q.; Zhu, J.; Wang, B.; Fang, X.; Zheng, Z.; Yawalkar, N.; et al. MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate. J. Clin. Med. 2022, 11, 4580. https://doi.org/10.3390/jcm11154580
Zhang Q, Lin J, Zhang Z, Han L, Huang Q, Zhu J, Wang B, Fang X, Zheng Z, Yawalkar N, et al. MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate. Journal of Clinical Medicine. 2022; 11(15):4580. https://doi.org/10.3390/jcm11154580
Chicago/Turabian StyleZhang, Qi, Jinran Lin, Zhenghua Zhang, Ling Han, Qiong Huang, Jie Zhu, Bing Wang, Xu Fang, Zhizhong Zheng, Nikhil Yawalkar, and et al. 2022. "MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate" Journal of Clinical Medicine 11, no. 15: 4580. https://doi.org/10.3390/jcm11154580
APA StyleZhang, Q., Lin, J., Zhang, Z., Han, L., Huang, Q., Zhu, J., Wang, B., Fang, X., Zheng, Z., Yawalkar, N., Liang, J., & Yan, K. (2022). MTHFR Polymorphism and Folic Acid Supplementation Influence Serum Homocysteine Levels in Psoriatic Patients Treated with Methotrexate. Journal of Clinical Medicine, 11(15), 4580. https://doi.org/10.3390/jcm11154580

